CN113631169A - 含有苯并氮杂卓化合物的药物组合物 - Google Patents

含有苯并氮杂卓化合物的药物组合物 Download PDF

Info

Publication number
CN113631169A
CN113631169A CN202080023549.6A CN202080023549A CN113631169A CN 113631169 A CN113631169 A CN 113631169A CN 202080023549 A CN202080023549 A CN 202080023549A CN 113631169 A CN113631169 A CN 113631169A
Authority
CN
China
Prior art keywords
pharmaceutical composition
formula
minutes
metal salt
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080023549.6A
Other languages
English (en)
Chinese (zh)
Inventor
千原远见彦
宇野真悟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of CN113631169A publication Critical patent/CN113631169A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN202080023549.6A 2019-03-28 2020-03-27 含有苯并氮杂卓化合物的药物组合物 Pending CN113631169A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-064357 2019-03-28
JP2019064357 2019-03-28
PCT/JP2020/013935 WO2020196816A1 (en) 2019-03-28 2020-03-27 Benzoazepine compound-containing pharmaceutical composition

Publications (1)

Publication Number Publication Date
CN113631169A true CN113631169A (zh) 2021-11-09

Family

ID=70289832

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080023549.6A Pending CN113631169A (zh) 2019-03-28 2020-03-27 含有苯并氮杂卓化合物的药物组合物

Country Status (7)

Country Link
US (1) US20220152064A1 (https=)
EP (1) EP3946362A1 (https=)
JP (3) JP7130879B2 (https=)
KR (1) KR20210144811A (https=)
CN (1) CN113631169A (https=)
EA (1) EA202192635A1 (https=)
WO (1) WO2020196816A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121081404A (zh) * 2025-11-12 2025-12-09 北京藏卫信康医药研发有限公司 含有托伐普坦磷酸钠的药物组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101346390A (zh) * 2005-12-27 2009-01-14 大塚制药株式会社 水溶性苯并氮杂化合物及其药物组合物
WO2015056805A1 (en) * 2013-10-15 2015-04-23 Otsuka Pharmaceutical Co., Ltd. Drug for preventing and/or treating polycystic kidney disease
JP2015134837A (ja) * 2007-06-26 2015-07-27 大塚製薬株式会社 医薬

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210144810A (ko) * 2019-03-28 2021-11-30 오츠카 세이야쿠 가부시키가이샤 벤조아제핀 화합물-함유 동결건조 조성물

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101346390A (zh) * 2005-12-27 2009-01-14 大塚制药株式会社 水溶性苯并氮杂化合物及其药物组合物
JP2015134837A (ja) * 2007-06-26 2015-07-27 大塚製薬株式会社 医薬
WO2015056805A1 (en) * 2013-10-15 2015-04-23 Otsuka Pharmaceutical Co., Ltd. Drug for preventing and/or treating polycystic kidney disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121081404A (zh) * 2025-11-12 2025-12-09 北京藏卫信康医药研发有限公司 含有托伐普坦磷酸钠的药物组合物
CN121081404B (zh) * 2025-11-12 2026-02-06 北京藏卫信康医药研发有限公司 含有托伐普坦磷酸钠的药物组合物

Also Published As

Publication number Publication date
US20220152064A1 (en) 2022-05-19
JP2022519343A (ja) 2022-03-23
JP2025081484A (ja) 2025-05-27
JP7130879B2 (ja) 2022-09-05
KR20210144811A (ko) 2021-11-30
JP2022163190A (ja) 2022-10-25
EA202192635A1 (ru) 2021-12-10
EP3946362A1 (en) 2022-02-09
WO2020196816A1 (en) 2020-10-01

Similar Documents

Publication Publication Date Title
CN113645954B (zh) 含有苯并氮杂卓化合物的冻干组合物
US5589491A (en) Injection and injection kit containing omeprazole and its analogs
JP2015164936A (ja) 置換２，３−ジヒドロイミダゾ［１，２−ｃ］キナゾリン塩類
OA12739A (en) Platinum derivative pharmaceutical formulations.
ES2324009B1 (es) Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo.
JP2014524467A (ja) デオキシコール酸およびその塩類の製剤
US9597283B2 (en) Injectable depot formulation comprising optically active tolvaptan and process of producing the same
JP2025081484A (ja) ベンゾアゼピン化合物含有医薬組成物
JPH0648945A (ja) 微粒子化薬剤およびその製法
HK40063746A (en) Benzoazepine compound-containing pharmaceutical composition
NL8102362A (nl) Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan.
CN100584835C (zh) 桂哌齐特的药用盐及其制备方法
HK40063745A (en) Benzoazepine compound-containing freeze-dried composition
HK40063745B (zh) 含有苯并氮杂卓化合物的冻干组合物
JPS6310685B2 (https=)
EA045403B1 (ru) Лиофилизированная композиция, содержащая соединение бензоазепина
JP3242924B2 (ja) 調製済みのアゾセミド（ａｚｏｓｅｍｉｄｅ）注射液
CA1252103A (en) Crystalline gluconate salt of 4'-(9-acridinylamino)- methanesulfo-m-anisidide
JP2001039874A (ja) 肺高血圧症予防治療剤
JP2002080361A (ja) Ｎ−［ｏ−（ｐ−ピバロイルオキシベンゼンスルホニルアミノ）ベンゾイル］グリシン・モノナトリウム塩・４水和物含有溶液および製剤
JPH08217675A (ja) インフルエンザ治療剤
JPS6330422A (ja) 抗悪性腫瘍効果増強剤
JPH03120216A (ja) 骨髄の抑制用組成物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40063746

Country of ref document: HK